Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits

Glioblastoma (GBM) is characterized by fast-growing cells, genetic and phenotypic heterogeneity, and radio-chemo-therapy resistance, contributing to its dismal prognosis. Various medical comorbidities are associated with the natural history of GBM. The most disabling and greatly affecting patients’...

Descripción completa

Detalles Bibliográficos
Autores principales: Stella, Manuela, Baiardi, Giammarco, Pasquariello, Stefano, Sacco, Fabio, Dellacasagrande, Irene, Corsaro, Alessandro, Mattioli, Francesca, Barbieri, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953000/
https://www.ncbi.nlm.nih.gov/pubmed/36831117
http://dx.doi.org/10.3390/biomedicines11020582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953000/
https://www.ncbi.nlm.nih.gov/pubmed/36831117
http://dx.doi.org/10.3390/biomedicines11020582

Ejemplares similares